New research highlights the key blockers and attitudes towards AI adoption by large European bio-pharmaceutical groups and technology startups. While artificial intelligence (AI) was …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
